|
| Press Releases |
|
 |
|
| Monday, June 25, 2018 |
|
|
Jacobson Pharma Announces 2018 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018"). more info >> |
|
|
雅各臣公布二零一八年全年业绩 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）今天公布公司及其附属公司（统称「集团」）于截至二零一八年三月三十一日止年度（「二零一八财年」）的全年业绩。
more info >> |
|
|
雅各臣公佈二零一八年全年業績 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）今天公佈公司及其附屬公司（統稱「集團」）於截至二零一八年三月三十一日止年度（「二零一八財年」）的全年業績。
more info >> |
|
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").
more info >> |
|
| Thursday, June 14, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score(R) results of 11 to 25. more info >> |
|
| Wednesday, June 13, 2018 |
|
|
雅各臣汇报TAILORx研究结果 |
| 雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）为全球领先的基因型诊断检测供应商Genomic Health, Inc. （「基美健」﹔纳斯达克： GHDX）的香港及澳门独家分销商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或「TAILORx」研究报告 more info >> |
|
|
雅各臣匯報TAILORx研究結果 |
| 雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）為全球領先的基因型診斷檢測供應商Genomic Health, Inc. （「基美健」﹔納斯達克：GHDX）的香港及澳門獨家分銷商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或 「TAILORx」研究報告 more info >> |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Jacobson Pharma Ranked No.1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
雅各臣获《FinanceAsia》杂志「2018年亚洲最佳企业选举」选为香港「最佳小型企业」首位 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）欣然宣布集团于亚洲权威财经杂志《FinanceAsia》举办的「2018年亚洲最佳企业选举」中，于香港「最佳小型企业」排名第一。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Carbonverse打造「碳資產+數字錢包+使用即挖礦」新生態
May 19, 2026 15:41 HKT/SGT
|
|
|
Vaiz introduces agile project management tools as teams leave Jira for simpler alternatives
May 19, 2026 15:00: JST
|
|
|
Vaiz introduces agile project management tools as teams leave Jira for simpler alternatives
May 19, 2026 14:00 HKT/SGT
|
|
|
SMBC Group, Fujitsu and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare
May 19, 2026 13:37 JST
|
|
|
SMBCグループ、富士通、ソフトバンク、健康・医療分野での業務提携に合意し、持続可能な医療の実現に向けて国産ヘルスケア基盤を構築
May 19, 2026 11:15: JST
|
|
|
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform
May 19, 2026 11:11 HKT/SGT
|
|
|
Anson Resources Engineering Study Confirms Green River as a Future Low-Cost Producer
May 19, 2026 10:40 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 19, 2026 10:16 HKT/SGT
|
|
|
宇樹科技、雲深處IPO進程提速 首程控股（697.HK）機器人投資進入價值驗證期
May 19, 2026 09:05 HKT/SGT
|
|
|
Unitree Robotics and DEEP Robotics Accelerate IPO Progress; Shoucheng Holdings' Robotics Investments Enter a Value Validation Phase
May 19, 2026 08:58 HKT/SGT
|
|
|
Shoucheng Holdings (697.HK): Robotics Investments Near Monetization Window as Dividends and Buybacks Strengthen Shareholder Returns
May 19, 2026 08:52 HKT/SGT
|
|
|
首程控股（697.HK）機器人投資即將進入兌現窗口 分紅回購強化股東回報
May 19, 2026 08:40 HKT/SGT
|
|
|
Ondas Inc. Stockholders: Vote Now to Ensure Quorum for Annual Meeting
May 19, 2026 05:30: JST
|
|
|
Ondas Inc. 股東：請立即投票，以確保年度股東大會達到法定人數
May 19, 2026 04:30 HKT/SGT
|
|
|
Ondas Inc. 各位股东：请立即投票，以确保年度股东大会达到法定人数佛罗里达州西棕榈
May 19, 2026 04:30 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
